Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational Discrete Choice Experiment Study
Ophthalmic Research · 2024
DOI: 10.1159/000541349 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Ophthalmic Research, 2024. Verfasst von Alfredo García-Layana und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Diabetic Retinopathy, Macular Edema, Patient Preference. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
New anti-vascular endothelial growth factor (VEGF) treatments are emerging for the treatment of diabetic macular edema (DME)/neovascular age-related macular degeneration (nAMD). This study aimed to explore the treatment attributes patients find important when deciding on treatment options.
Methods
This noninterventional survey study assessed treatment preferences through a discrete choice experiment (DCE) among patients with DME/nAMD in the USA, Canada, France, Italy, Spain, and the UK. The DCE design was informed by a targeted literature review and qualitative interview research and included five treatment attributes: mode of administration, frequency of examinations, frequency of injections or refills, likely change in visual acuity, and eye-related side effects. Conditional logit models were used to analyze the choice data.
Results
Overall, 537 patients completed the DCE (DME, n = 173; nAMD, n = 364). Patients reported preferring “injection” over “implant surgery and refills” and better visual outcomes over “stabilization,” which were also the most important attributes driving preference (35.1% and 31.5%, respectively). They also showed a preference for less-frequent treatment and examinations and for “mild-moderate, frequent” over “severe, rare” side effects. These findings were generally consistent across the two conditions, although significant differences were found depending on anti-VEGF treatment duration (nAMD, DME) and number of reported barriers (nAMD).
Conclusion
Patient preferences for treatment are driven by several factors. Considering these preferences is essential when designing/introducing new therapies. Individual treatment preferences should be identified and given key consideration when helping patients select from an expanding array of treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
- Genentech, Inc., South San Francisco, California, USA.
- Department of Ophthalmology, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
- UMR-CNRS 5510 Matéis, Insa, University of Lyon, Lyon, France.
- IRCCS-Fondazione Bietti, Rome, Italy.
- Toronto Retina Institute, Toronto, Ontario, Canada.
Zitieren
APA
García-Layana, A., Chi, G. C., Kodjikian, L., Parravano, M., Chow, D., Jackson, T. L., Danzig, C., Paris, L. P., Mirt, M., Henry-Szatkowski, M., Lewis, H. B., & Gentile, B. (2024). Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational Discrete Choice Experiment Study. Ophthalmic Research. https://doi.org/10.1159/000541349
Vancouver
García-Layana A, Chi GC, Kodjikian L, Parravano M, Chow D, Jackson TL, et al. Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational Discrete Choice Experiment Study. Ophthalmic Research. 2024. doi:10.1159/000541349
BibTeX
@article{GarcaLayana2024,
author = {García-Layana, Alfredo and Chi, Gloria C and Kodjikian, Laurent and Parravano, Mariacristina and Chow, David and Jackson, Timothy L and Danzig, Carl and Paris, Liliana P and Mirt, Mirela and Henry-Szatkowski, Mickael and Lewis, Hannah B and Gentile, Brittany},
title = {Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational Discrete Choice Experiment Study},
journal = {Ophthalmic Research},
year = {2024},
doi = {10.1159/000541349}
}
EUVIMED